MSC-INHP-QHCP-1: Questioner to Health Care Professionals and Regulatory Authorities (Questioner to HCPs and RAs, Study MSC-INHP-8797)

Study identification

• EU PAS number:
  EUPAS8797
• Study ID:
  8798
• Official title and acronym:
  MSC-INHP-QHCP-1: Questioner to Health Care Professionals and Regulatory Authorities (Questioner to HCPs and RAs, Study MSC-INHP-8797)
• DARWIN EU® study:
  No
• Study countries:
  Hungary

  Poland

  Switzerland

  Türkiye

  United Kingdom
• Study description:
  The aim and objective of the Study MSC-INHP-8797 addressed to health care professionals and regulatory authorities is to measure current and future standard care of cancer therapy and monitor patient outcome.The Study MSC-INHP-8797 examines and follows up on current and future work ethics, believes and knowledge regarding marketing, distribution, prescription, and use of drugs in a society, with special emphasis on patient outcome i.e the resulting medical, social and economic consequences of new drug developments such as “The Biosimilars” .
• Study status:
  Planned

Research institutions and networks

Institutions

Best Care Consulting

Networks

MSC-INHP

Study timelines

Date when funding contract was signed

Planned:11/03/2015

Study start date

Planned:11/03/2015

Date of interim report, if expected

Planned:11/06/2015

Date of final study report

Planned:11/06/2020

Sources of funding

Pharmaceutical company and other private sector 

Other

More details on funding

Best Care Consulting, MSC-INHPs

Regulatory

• Was the study required by a regulatory body?:
  No